What Scientists Can Do

On Sept. 11, did you feel as you wanted to help, but could not, as you were numb? I sat bleary-eyed in front of the TV, despite being a professor of epidemiology. I did not know what I could do. Perhaps the best approach we as scientists can take is the building of a global scientist Civil Defense. About two weeks before Sept. 11, my colleagues and I published in the Lancet an article suggesting that the public health and scientific systems guarding against a terrorist attack were in adequate.

Written byRonald Laporte
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The systems in place on Sept. 10 were too rigid, too hierarchical with too few eyes and brains. We argued for a Citizen and Scientific neighborhood watch, in which we as citizens and scientists would be interconnected with our friends. This virtual set of global networks would have 50 million eyes and 25 million brains to be on the outlook for terrorism, and to mitigate panic should attacks take place. The concept is simple, take the civil defense technologies that worked quite well in the 1940s-60s in the United States and many other countries, and ramp them up onto the Internet.

Scientists are in a unique position to prevent terrorism and to reduce fear and panic as we ourselves have developed many of the agents and pathogens. We know what to look for, we are viewed in the community as wise, so we can reduce fear, and we unknowingly train ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies